Vaginal mucoadhesive drug delivery systems

Drug Development and Industrial Pharmacy

Volumn 38, Issue 6, 2012, Pages 643-652

  De Araújo Pereira, Raphaela Regina ^a   Bruschi, Marcos Luciano ^a  

^a STATE UNIVERSITY OF MARINGÁ   (Brazil)

Author keywords

Drug delivery systems; Mucoadhesion; Vaginal mucosa; Vaginal route; Vaginitis

Indexed keywords

ACETIC ACID; ADVANTAGE S; ALGINIC ACID; AMPHOTERICIN B; BUFFER GEL; CARBOMER; CARBOXYMETHYLCELLULOSE; CELLULOSE DERIVATIVE; CHITOSAN; CLINDAMYCIN; CLOMIREX; CLOTRIMAZOLE; CYCLODEXTRIN DERIVATIVE; ESTRADIOL; ETHYLENE OXIDE; FLUCONAZOLE; GLYCAN DERIVATIVE; GUAR GUM; GYNAZOLE; HYDROXYPROPYLCELLULOSE; HYDROXYPROPYLMETHYLCELLULOSE; ITRACONAZOLE; K Y JELLY; KETOCONAZOLE; LIPOSOME; METRONIDAZOLE; MICONAZOLE; MIFLUOR; NONOXINOL 9; POLOXAMER; POLYCARBOPHIL; POLYMER; POVIDONE; PRO 2000 5; PROGESTERONE; PROPYLENE OXIDE; PROSTAGLANDIN E2; SYNPERONIC; TETRONIC; TETRONIC ACID DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VORICONAZOLE; XANTHAN;

DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM; DRUG RELEASE; DRUG TRANSPORT; HUMAN; IMMUNIZATION; INTESTINE MUCOSA; NONHUMAN; RECTUM; REVIEW; VAGINA CANDIDIASIS; VAGINA MUCOSA;

ADHESIVENESS; ADMINISTRATION, INTRAVAGINAL; DRUG DELIVERY SYSTEMS; FEMALE; HUMANS; MUCOUS MEMBRANE; PHARMACEUTICAL PREPARATIONS; VAGINA;

EID: 84860358871     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639045.2011.623355     Document Type: Review

References (64)

1. Bachhav YG, Patravale VB. (2009). Microemulsion based vaginal gel of fluconazole: Formulation, in vitro and in vivo evaluation. Int J Pharm, 365:175-179
2. Baloglu E, Senyigit ZA, Karavana SY, Bernkop-Schnürch A. (2009). Strategies to prolong the intravaginal residence time of drug delivery systems. J Pharm Pharm Sci, 12:312-336
3. Hussain A, Ahsan F. (2005). The vagina as a route for systemic drug delivery. J Control Release, 103:301-313 (Pubitemid 40342532)
4. Shaikh R, Raj Singh TR, Garland MJ, Woolfson AD, Donnelly RF. (2011). Mucoadhesive drug delivery systems. J Pharm Bioallied Sci, 3:89-100
5. Valenta C. (2005). The use of mucoadhesive polymers in vaginal delivery. Adv Drug Deliv Rev, 57:1692-1712 (Pubitemid 41444256)
6. Yoo JW, Dharmala K, Lee CH. (2006). The physicodynamic properties of mucoadhesive polymeric films developed as female controlled drug delivery system. Int J Pharm, 309:139-145 (Pubitemid 43129476)
7. Ndesendo VM, Pillay V, Choonara YE, du Toit LC, Buchmann E, Meyer LC et al. (2010). Investigation of the physicochemical and physicomechanical properties of a novel intravaginal bioadhesive polymeric device in the pig model. AAPS PharmSciTech, 11:793-808
8. Pavelic Z, Skalko-Basnet N, Jalsenjak I. (2004). Liposomal gel with chloramphenicol: Characterisation and in vitro release. Acta Pharm, 54:319-330 (Pubitemid 40143817)
9. Bhowmik BB, Nayak BS, Chatterjee A. (2009). Formulation development and characterization of metronidazole microencapsulated bioadhesive vaginal gel. Int J Pharm Pharmaceut Sci, 1:240-257
10. Albertini B, Passerini N, Di Sabatino M, Vitali B, Brigidi P, Rodriguez L. (2009). Polymer-lipid based mucoadhesive microspheres prepared by spray-congealing for the vaginal delivery of econazole nitrate. Eur J Pharm Sci, 36:591-601
11. Bilensoy E, Rouf MA, Vural I, Sen M, Hincal AA. (2006). Mucoadhesive, thermosensitive, prolonged-release vaginal gel for clotrimazole: β-cyclodextrin complex. AAPS PharmSciTech, 7:38
12. Ceschel GC, Maffei P, Lombardi Borgia S, Ronchi C, Rossi S. (2001). Development of a mucoadhesive dosage form for vaginal administration. Drug Dev Ind Pharm, 27:541-547 (Pubitemid 32803573)
13. Chang JY, Oh YK, Kong HS, Kim EJ, Jang DD, Nam KT et al. (2002). Prolonged antifungal effects of clotrimazole-containing mucoadhesive thermosensitive gels on vaginitis. J Control Release, 82:39-50
14. Francois M, Snoeckx E, Putteman P, Wouters F, De Proost E, Delaet U et al. (2003). A mucoadhesive, cyclodextrin-based vaginal cream formulation of itraconazole. AAPS PharmSci, 5:5
15. Gupta H, Sharma A. (2009). Ion activated bioadhesive in situ gel of clindamycin for vaginal application. Int J Drug Del, 1:32-40
16. Patel GM, Patel AP. (2010). A novel effervescent bioadhesive vaginal tablet of ketoconazole: Formulation band in vitro evaluation. Int J PharmTech Res, 2:656-667
17. Sharma G, Jain S, Tiwary AK, Kaur G. (2006). Once daily bioadhesive vaginal clotrimazole tablets: Design and evaluation. Acta Pharm, 56:337-345 (Pubitemid 44422513)
18. Wang L, Tang X. (2008). A novel ketoconazole bioadhesive effervescent tablet for vaginal delivery: Design, in vitro and in vivo evaluation. Int J Pharm, 350:181-187
19. (Pubitemid 44921901)
20. Patel DB, Patel JK. (2009). Liposomal drug delivery of metronidazole for the local treatment of vaginitis. Int J Pharm Sci Nanotech, 2:421-427
21. Perioli L, Ambrogi V, Pagano C, Scuota S, Rossi C. (2009a). FG90 chitosan as a new polymer for metronidazole mucoadhesive tablets for vaginal administration. Int J Pharm, 377:120-127
22. Perioli L, Ambrogi V, Venezia L, Pagano C, Ricci M, Rossi C. (2008). Chitosan and a modified chitosan as agents to improve performances of mucoadhesive vaginal gels. Colloids Surf B Biointerfaces, 66:141-145
23. Simoes JA, Bahamondes LG, Camargo RP, Alves VM, Zaneveld LJ, Waller DP et al. (2006). A pilot clinical trial comparing an acidbuffering formulation (ACIDFORM gel) with metronidazole gel for the treatment of symptomatic bacterial vaginosis. Br J Clin Pharmacol, 61:211-217 (Pubitemid 43382614)
24. Acquarone M, Blasi N, Casella M, Ciangherotti F, Conforti M, Corradini E, Della Sala MR, Mannu L, Sbrignadello C, Senatori R, Stigliano CM. (2008). Efficacy and tolerability of a 0.25% chlorhexidine-based vaginal gel (Clomirex?) in non-pregnant women with bacterial vaginosis. Results of a multicenter, openlabel trial. Eur Bull Drug Res, 16:1-4
25. Ahmad FJ, Alam MA, Khan ZI, Khar RK, Ali M. (2008). Development and in vitro evaluation of an acid buffering bioadhesive vaginal gel for mixed vaginal infections. Acta Pharm, 58:407-419
26. Alam MA, Ahmad FJ, Khan ZI, Khar RK, Ali M. (2007). Development and evaluation of acid-buffering bioadhesive vaginal tablet for mixed vaginal infections. AAPS PharmSciTech, 8:109
27. Chopra S, Motwani SK, Iqbal Z, Talegaonkar S, Ahmad FJ, Khar RK. (2007). Optimisation of polyherbal gels for vaginal drug delivery by Box-Behnken statistical design. Eur J Pharm Biopharm, 67:120-131 (Pubitemid 46991318)
28. Garg S, Vermani K, Garg A, Anderson RA, Rencher WB, Zaneveld LJ. (2005). Development and characterization of bioadhesive vaginal films of sodium polystyrene sulfonate (PSS), a novel contraceptive antimicrobial agent. Pharm Res, 22:584-595 (Pubitemid 40603256)
29. Ramadan AA. (2008). Formulation and evaluation of bioadhesive gels containing miconazole nitrate. J App. Sci Res, 4:1052-1065
30. Bilensoy E, Çirpanli Y, Şen M, Doǧan L, Çaliş S. (2007). Thermosensitive mucoadhesive gel formulation loaded with 5-Fu: Cyclodextrin complex for HPV-induced cervical cancer. J Incl Phenom Macrocycl Chem, 57:363-370
31. Bilensoy E, Moroy P, Çirpanli Y, Bilensoy T, Çaliş S, Mollamahmutoglu L. (2011). A double-blind placebocontrolled study of 5-fluorouracil: Cyclodextrin complex loaded thermosensitive gel for the treatment of HPV induced condyloma. J Incl Phenom Macrocycl Chem, 69:309-313
32. Goodsell A, Zhou F, Gupta S, Singh M, Malyala P, Kazzaz J et al. (2008). β7-integrin-independent enhancement of mucosal and systemic anti-HIV antibody responses following combined mucosal and systemic gene delivery. Immunology, 123:378-389 (Pubitemid 351171190)
33. Han IK, Kim YB, Kang HS, Sul D, Jung WW, Cho HJ et al. (2006). Thermosensitive and mucoadhesive delivery systems of mucosal vaccines. Methods, 38:106-111 (Pubitemid 43163470)
34. Perioli L, Ambrogi V, Pagano C, Massetti E, Rossi C. (2011). New solid mucoadhesive systems for benzydamine vaginal administration. Colloids Surf B Biointerfaces, 84:413-420
35. Perioli L, Ambrogi V, Venezia L, Giovagnoli S, Pagano C, Rossi C. (2009b). Formulation studies of benzydamine mucoadhesive formulations for vaginal administration. Drug Dev Ind Pharm, 35:769-779
36. Zaneveld LJ, Waller DP, Ahmad N, Quigg J, Kaminski J, Nikurs A et al. (2001). Properties of a new, long-lasting vaginal delivery system (LASRS) for contraceptive and antimicrobial agents. J Androl, 22:481-490 (Pubitemid 32322140)
37. Ahuja A, Khar RK, Ali J. (1997). Mucoadhesive drug delivery systems. Drug Dev Ind Pharm, 23:489-515 (Pubitemid 27241128)
38. Rohan LC, Sassi AB. (2009). Vaginal drug delivery systems for HIV prevention. AAPS Pharm Sci Tech, 11:78-87
39. Andrews GP, Laverty TP, Jones DS. (2009b). Mucoadhesive polymeric platforms for controlled drug delivery. Eur J Pharm Biopharm, 71:505-518
40. Duchêne D, Ponchel G. (1992). Principle and investigation of the bioadhesion mechanism of solid dosage forms. Biomaterials, 13:709-714
41. Carvalho FC, Bruschi ML, Evangelista RC, Gremião MPD. (2010). Mucoadhesive drug delivery systems. Braz J Pharm Sci, 46:1-18
42. Lai SK, Wang YY, Hida K, Cone R, Hanes J. (2010). Nanoparticles reveal that human cervicovaginal mucus is riddled with pores larger than viruses. Proc Natl Acad Sci USA, 107:598-603
43. Bruschi ML, de Freitas O. (2005). Oral bioadhesive drug delivery systems. Drug Dev Ind Pharm, 31:293-310 (Pubitemid 40463973)
44. Bruschi ML, Jones DS, Panzeri H, Gremião MP, de Freitas O, Lara EH. (2007). Semisolid systems containing propolis for the treatment of periodontal disease: in vitro release kinetics, syringeability, rheological, textural, and mucoadhesive properties. J Pharm Sci, 96:2074-2089 (Pubitemid 47280102)
45. Farage M, Maibach H. (2006). Lifetime changes in the vulva and vagina. Arch Gynecol Obstet, 273:195-202 (Pubitemid 43004689)
46. Boris S, Suárez JE, Vázquez F, Barbés C. (1998). Adherence of human vaginal lactobacilli to vaginal epithelial cells and interaction with uropathogens. Infect Immun, 66:1985-1989 (Pubitemid 28194093)
47. Vásquez A, Jakobsson T, Ahrné S, Forsum U, Molin G. (2002). Vaginal lactobacillus flora of healthy Swedish women. J Clin Microbiol, 40:2746-2749 (Pubitemid 35284935)
48. Dota KFD, Consolaro MEL, Svidzinski TIE, Bruschi ML. (2010). Antifungal activity of brazilian propolis microparticles against yeasts isolated from vulvovaginal candidiasis. eCAM Adv Access, 12:1-8
49. Vitali B, Pugliese C, Biagi E, Candela M, Turroni S, Bellen G et al. (2007). Dynamics of vaginal bacterial communities in women developing bacterial vaginosis, candidiasis, or no infection, analyzed by PCR-denaturing gradient gel electrophoresis and realtime PCR. Appl Environ Microbiol, 73:5731-5741 (Pubitemid 47462983)
50. Bruschi ML. (2006). Desenvolvimento e caracterização de sistemas de liberação de própolis intrabolsa periodontal. Doctorate thesis, Pharmaceutical Sciences Faculty, São Paulo University, Ribeirão Preto, Brazil
51. Chidambaram N, Srivatsava AK. (1995). Buccal drug delivery systems. Drug Dev Ind Pharm, 21:1009-1036
52. das Neves J, Amaral MH, Bahia MF. (2008). Performance of an in vitro mucoadhesion testing method for vaginal semisolids: Influence of different testing conditions and instrumental parameters. Eur J Pharm Biopharm, 69:622-632
53. Álvares CA, Svidzinski TIE, Consolaro MEL. (2007). Candidíase vulvovaginal: Fatores predisponentes do hospedeiro e virulência das leveduras. J Bras Patol Med Lab, 43:319-327
54. Ferris DG, Nyirjesy P, Sobel JD, Soper D, Pavletic A, Litaker MS. (2002). Over-the-counter antifungal drug misuse associated with patient-diagnosed vulvovaginal candidiasis. Obstet Gynecol, 99:419-425 (Pubitemid 34188402)
55. Ferrazza MHSH, Maluf MLF, Consolaro MEL, Shinobu CS, Svidzinski, TIE, Batista MR. (2005). Caracterização de leveduras isoladas da vagina e sua associação com candidíase vulvovaginal em duas cidades do sul do Brasil. Rev Bras Gin Obstet, 27:58-63
56. Harrison PF. (2000). Microbicides: Forging scientific and political alliances. AIDS Patient Care STDS, 14:199-205 (Pubitemid 30225314)
57. Dumortier G, Grossiord JL, Agnely F, Chaumeil JC. (2006). review of poloxamer 407 pharmaceutical and pharmacological characteristics. Pharm Res, 23:2709-2728 (Pubitemid 44885361)
58. Jones DS, Bruschi ML, de Freitas O, Gremião MP, Lara EH, Andrews GP. (2009). Rheological, mechanical and mucoadhesive properties of thermoresponsive, bioadhesive binary mixtures composed of poloxamer 407 and carbopol 974P designed as platforms for implantable drug delivery systems for use in the oral cavity. Int J Pharm, 372:49-58
59. Valenta C, Kast CE, Harich I, Bernkop-Schnürch A. (2001). Development and in vitro evaluation of a mucoadhesive vaginal delivery system for progesterone. J Control Release, 77: 323-332 (Pubitemid 33145483)
60. Kast CE, Valenta C, Leopold M, Bernkop-Schnürch A. (2002). Design and in vitro evaluation of a novel bioadhesive vaginal drug delivery system for clotrimazole. J Control Release, 81:347-354 (Pubitemid 34607154)
61. Bonferoni MC, Giunchedi P, Scalia S, Rossi S, Sandri G, Caramella C. (2006). Chitosan gels for the vaginal delivery of lactic acid: Relevance of formulation parameters to mucoadhesion and release mechanisms. AAPS PharmSciTech, 7:104
62. D Cruz OJ, Samuel P, Uckun FM. (2005). Conceival, a novel noncontraceptive vaginal vehicle for lipophilic microbicides. AAPS PharmSciTech, 6:56-64
63. Curran RM, Donnelly L, Morrow RJ, Fraser C, Andrews G, Cranage M et al. (2009). Vaginal delivery of the recombinant HIV-1 clade-C trimeric gp140 envelope protein CN54gp140 within novel rheologically structured vehicles elicits specific immune responses. Vaccine, 27:6791-6798
64. El-Kamel A, Sokar M, Naggar V, Al Gamal S. (2002). Chitosan and sodium alginate-based bioadhesive vaginal tablets. AAPS PharmSci, 4:44